AB InBev vs Altria
Major brewer with diverse beer brands worldwide vs Major US tobacco company with steady dividend payments. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
AB InBev is the world's largest brewer by volume with global brands like Budweiser and Corona and a track record of aggressive cost-cutting after acquisitions, while Altria sells cigarettes in a structurally declining U.S. market and is pivoting toward smoke-free products with mixed results. AB InBev vs Altria both generate enormous free cash flow from their respective vice industries, but one is building global scale while the other is managing a slow-motion volume decline. This comparison examines how their pricing power, dividend sustainability, and strategic pivots translate into shareholder returns.
AB InBev is the world's largest brewer by volume with global brands like Budweiser and Corona and a track record of aggressive cost-cutting after acquisitions, while Altria sells cigarettes in a struc...
Why It’s Moving
BUD is holding up as analysts lean bullish on earnings momentum and reinvestment plans.
- Analyst sentiment stayed constructive after several firms reiterated bullish views in early August, helping frame BUD as a name with steady earnings momentum rather than a fresh turnaround story.
- Recent Q2 results showed better-than-expected profitability and a reaffirmed full-year outlook, which eased concerns about margin pressure and supported the stock’s resilience.
- A new U.S. brewery investment announcement added a modest growth signal, reinforcing the idea that management is still investing in capacity and local operations despite a cautious consumer backdrop.
MO stays under pressure as slower tobacco growth and legal headlines keep analysts cautious
- Analysts remain cautious after Altria’s latest quarter, where revenue came in only slightly above year-ago levels and cigarette volume trends stayed under pressure, reinforcing worries about slower core business growth.
- Recent coverage points to a continued split between sturdy cash generation and a fading traditional smoking market, which keeps attention on whether smokeless products can offset declines fast enough.
- Investor sentiment has also been weighed by fresh legal and securities-investigation headlines around the stock, adding another layer of uncertainty even as some firms continue to accumulate shares.
BUD is holding up as analysts lean bullish on earnings momentum and reinvestment plans.
- Analyst sentiment stayed constructive after several firms reiterated bullish views in early August, helping frame BUD as a name with steady earnings momentum rather than a fresh turnaround story.
- Recent Q2 results showed better-than-expected profitability and a reaffirmed full-year outlook, which eased concerns about margin pressure and supported the stock’s resilience.
- A new U.S. brewery investment announcement added a modest growth signal, reinforcing the idea that management is still investing in capacity and local operations despite a cautious consumer backdrop.
MO stays under pressure as slower tobacco growth and legal headlines keep analysts cautious
- Analysts remain cautious after Altria’s latest quarter, where revenue came in only slightly above year-ago levels and cigarette volume trends stayed under pressure, reinforcing worries about slower core business growth.
- Recent coverage points to a continued split between sturdy cash generation and a fading traditional smoking market, which keeps attention on whether smokeless products can offset declines fast enough.
- Investor sentiment has also been weighed by fresh legal and securities-investigation headlines around the stock, adding another layer of uncertainty even as some firms continue to accumulate shares.
Investment Analysis
AB InBev
BUD
Pros
- Portfolio of globally recognised beer brands provides stable cash flows and resilience against regional downturns.
- Consistent dividends and large-scale operations support shareholder returns, with recent margin expansion despite top-line pressures.
- Ongoing innovation and packaging launches aim to capture growth in both beer and non-alcoholic segments, including expansion into new formats and markets.
Considerations
- Recent quarterly results show significant volume declines in key markets like China, leading to double-digit drops in revenue and EBITDA.
- Exposure to emerging markets increases vulnerability to currency fluctuations and local economic instability.
- Intense competition and shifting consumer preferences toward craft and non-alcoholic beverages challenge traditional beer growth.
Altria
MO
Pros
- Strong free cash flow generation from core tobacco operations enables significant share buybacks and consistent dividend payments.
- Diversified product portfolio, including reduced-risk tobacco products, provides some insulation against long-term cigarette decline.
- Recent monetisation of a portion of its large Anheuser-Busch InBev stake demonstrates ability to unlock value from non-core investments.
Considerations
- Core tobacco business faces secular decline in cigarette volumes due to health concerns and regulatory pressures, especially in developed markets.
- Heavy reliance on the US market increases exposure to domestic regulatory and litigation risks.
- Recent share sales in Anheuser-Busch InBev reduce a historically stable source of dividend income and capital gains.
AB InBev (BUD) Next Earnings Date
The next earnings date for BUD is expected on October 29, 2026. This report will cover Q3 2026 results, based on the company’s standard late-October reporting pattern following its July second-quarter release. If the date shifts, it will most likely remain in that late-October window.
Altria (MO) Next Earnings Date
The next expected earnings date for MO is October 29, 2026, based on its established reporting pattern. The upcoming release should cover Q3 2026 results. This timing is consistent with Altria’s prior quarterly schedule, with earnings typically reported near the end of the month after quarter-end.
AB InBev (BUD) Next Earnings Date
The next earnings date for BUD is expected on October 29, 2026. This report will cover Q3 2026 results, based on the company’s standard late-October reporting pattern following its July second-quarter release. If the date shifts, it will most likely remain in that late-October window.
Altria (MO) Next Earnings Date
The next expected earnings date for MO is October 29, 2026, based on its established reporting pattern. The upcoming release should cover Q3 2026 results. This timing is consistent with Altria’s prior quarterly schedule, with earnings typically reported near the end of the month after quarter-end.
Buy BUD or MO in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
